Page 80 - ITPS-7-3

INNOSC Theranostics and
Pharmacological Sciences Enhancers and SEs in cancer treatment

imprinted human SNURF-SNRPN locus. Nucleic Acids Res. doi: 10.1073/pnas.1424028112
2005;33(15):4740-4753.
16. Kim TK, Hemberg M, Gray JM, et al. Widespread
doi: 10.1093/nar/gki786 transcription at neuronal activity-regulated enhancers.
Nature. 2010;465(7295):182-187.
5. Panigrahi A, O’Malley BW. Mechanisms of enhancer action:
The known and the unknown. Genome Biol. 2021;22(1):108. doi: 10.1038/nature09033
doi: 10.1186/s13059-021-02322-1 17. De Santa F, Barozzi I, Mietton F, et al. A large fraction of
extragenic RNA pol II transcription sites overlap enhancers.
6. Tang F, Yang Z, Tan Y, Li Y. Super-enhancer function and PLoS Biol. 2010;8(5):e1000384.
its application in cancer targeted therapy. NPJ Precis Oncol.
2020;4(1):2. doi: 10.1371/journal.pbio.1000384
doi: 10.1038/s41698-020-0108-z 18. Djebali S, Davis CA, Merkel A, et al. Landscape
of transcription in human cells. Nature. 2012;
7. Pott S, Lieb JD. What are super-enhancers? Nat Genet. 489(7414):101-108.
2015;47(1):8-12.
doi: 10.1038/nature11233
doi: 10.1038/ng.3167
19. Hasty P, Montagna C. Chromosomal rearrangements in
8. Huang J, Li K, Cai W, et al. Dissecting super-enhancer cancer: Detection and potential causal mechanisms. Mol
hierarchy based on chromatin interactions. Nat Commun. Cell Oncol. 2014;1(1):e29904.
2018;9(1):943.
doi: 10.4161/mco.29904
doi: 10.1038/s41467-018-03279-9
20. Harewood L, Fraser PJ. The impact of chromosomal
9. Beacon TH, Delcuve GP, López C, et al. The dynamic broad rearrangements on regulation of gene expression. Hum Mol
epigenetic (H3K4me3, H3K27ac) domain as a mark of Genet. 2014;23(R1):R76-R82.
essential genes. Clin Epigenetics. 2021;13:1-17.
doi: 10.1093/hmg/ddu278
doi: 10.1186/s13148-021-01126-1
21. Alonso S, Dow LE. Engineering chromosome rearrangements
10. Creyghton MP, Cheng AW, Welstead GG, et al. Histone in cancer. Dis Model Mech. 2021;14(9):dmm049078.
H3K27ac separates active from poised enhancers and
predicts developmental state. Proc Natl Acad Sci U S A. doi: 10.1242/dmm.049078
2010;107(50):21931-21936. 22. Willis NA, Rass E, Scully RJ. Deciphering the code of the
doi: 10.1073/pnas.1016071107 cancer genome: Mechanisms of chromosome rearrangement.
Trends Cancer. 2015;1(4):217-230.
11. Zentner GE, Tesar PJ, Scacheri PC. Epigenetic signatures
distinguish multiple classes of enhancers with distinct doi: 10.1016/j.trecan.2015.10.007
cellular functions. Genome Res. 2011;21(8):1273-1283. 23. Ryan RJ, Drier Y, Whitton H, et al. Detection of enhancer-
doi: 10.1101/gr.122382.111 associated rearrangements reveals mechanisms of oncogene
dysregulation in B-cell lymphoma. Cancer Discov.
12. Raisner R, Kharbanda S, Jin L, et al. Enhancer activity 2015;5(10):1058-1071.
requires CBP/P300 bromodomain-dependent histone
H3K27 acetylation. Cell Rep. 2018;24(7):1722-1729. doi: 10.1158/2159-8290.CD-15-0370
doi: 10.1016/j.celrep.2018.07.041 24. Gröschel S, Sanders MA, Hoogenboezem R, et al. A single
oncogenic enhancer rearrangement causes concomitant
13. Durbin AD, Wang T, Wimalasena VK, et al. EP300 selectively EVI1 and GATA2 deregulation in leukemia. Cell. 2014;
controls the enhancer landscape of MYCN-amplified 157(2):369-381.
neuroblastoma. Cancer Discov. 2022;12(3):730-751.
doi: 10.1016/j.cell.2014.02.019
doi: 10.1158/2159-8290.CD-21-0385
25. Kandaswamy R, Sava GP, Speedy HE, et al. Genetic
14. Rubio K, Singh I, Dobersch S, et al. Inactivation of nuclear predisposition to chronic lymphocytic leukemia is
histone deacetylases by EP300 disrupts the MiCEE mediated by a BMF super-enhancer polymorphism. Cell
complex in idiopathic pulmonary fibrosis. Nat Commun. Rep. 2016;16(8):2061-2067.
2019;10(1):2229.
doi: 10.1016/j.celrep.2016.07.053
doi: 10.1038/s41467-019-10066-7
26. Bonev B, Cavalli G. Organization and function of the 3D
15. Hah N, Benner C, Chong LW, Yu RT, Downes M, Evans RM. genome. Nat Rev Genet. 2016;17(11):661-678.
Inflammation-sensitive super enhancers form domains of
coordinately regulated enhancer RNAs. Proc Natl Acad Sci doi: 10.1038/nrg.2016.112
U S A. 2015;112(3):E297-E302. 27. Dixon JR, Selvaraj S, Yue F, et al. Topological domains in

Volume 7 Issue 3 (2024) 9 doi: 10.36922/itps.3654